Moreover, CCL3 plays a vital role in promoting EMT via the PI3K-protein kinase B (Akt)-mTOR signaling pathway in breast cancer cells when co-cultured with myeloid-derived suppressor cells [30]. This evidence concerns the gene MTOR and breast carcinoma.